Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.38 trillion and total revenue of $115.78 billion.
Market Cap
1.38T
Revenue
115.78B
Profits
-39.7B
PE Ratio
n/a
Profit Margin
-34.29%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.79B | -0.08% | 766,875 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 82.73B | -0.66% | 671,942 | 15.53B |
| 3 | ARGX | argenx SE | 63.06B | -2.76% | 318,415 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 55.45B | -4.30% | 31,709,821 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.35B | 1.01% | 1,597,883 | - |
| 6 | ONC | BeOne Medicines AG | 42.29B | -0.66% | 351,537 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.26B | 0.03% | 2,357,484 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.58B | -0.09% | 1,799,736 | 4.80B |
| 9 | BNTX | BioNTech SE | 28.34B | -3.22% | 1,850,603 | 3.03B |
| 10 | INSM | Insmed Incorporated | 27.07B | -1.42% | 1,340,546 | 1.14B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.26B | 0.17% | 5,117,075 | 7.53M |
| 12 | INCY | Incyte Corporation | 25.94B | 0.13% | 799,410 | 5.82B |
| 13 | GMAB | Genmab A/S | 19.69B | -1.29% | 3,246,442 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.55B | -0.53% | 329,915 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.52B | 0.07% | 419,912 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.85B | -0.53% | 1,113,353 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.52B | 0.87% | 2,422,929 | 2.44B |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.32B | 0.81% | 1,012,648 | 830.81M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.60B | -2.44% | 2,264,338 | 3.41B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.33B | 0.43% | 1,271,296 | 1.66B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.25B | -0.44% | 1,104,360 | 669.50M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.83B | -0.92% | 145,147 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.35B | 0.21% | 2,001,577 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.76B | -1.14% | 292,776 | 776.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.72B | 0.33% | 1,210,572 | 67.67M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.71B | 1.04% | 1,290,086 | 5.67M |
| 27 | IONS | Ionis Pharmaceuticals, Inc. | 10.31B | 3.85% | 2,206,470 | 874.09M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 10.28B | -2.10% | 265,005 | 7.46M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.03% | 1,148,993 | - |
| 30 | SMMT | Summit Therapeutics Inc. | 10.16B | -3.27% | 4,388,983 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 10.11B | -1.40% | 236,181 | 440.48M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 10.07B | 1.04% | 465,873 | 105.00M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 10.01B | 0.26% | 476,085 | 281.99M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.40B | 0.15% | 640,568 | - |
| 35 | PCVX | Vaxcyte, Inc. | 9.21B | -1.20% | 662,064 | - |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.11% | 908,497 | 42.16M |
| 37 | IMVT | Immunovant, Inc. | 8.95B | -2.37% | 1,189,296 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.03B | -2.70% | 5,613,029 | 165.79M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.94B | 3.21% | 2,830,438 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.67B | 1.31% | 399,301 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.38B | -0.53% | 5,801,578 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 7.09B | 3.01% | 1,207,308 | - |
| 43 | CGON | CG Oncology, Inc. | 6.93B | -1.98% | 1,158,403 | 6.23M |
| 44 | ORKA | Oruka Therapeutics, Inc. | 6.78B | -5.13% | 992,194 | - |
| 45 | BLTE | Belite Bio, Inc | 6.40B | -1.36% | 135,333 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 6.29B | -1.36% | 985,120 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | 0.43% | 367,572 | 618.07M |
| 48 | DNTH | Dianthus Therapeutics, Inc. | 6.16B | -0.93% | 529,833 | 1.90M |
| 49 | ERAS | Erasca, Inc. | 6.16B | -0.17% | 2,244,359 | - |
| 50 | TVTX | Travere Therapeutics, Inc. | 6.15B | -0.75% | 1,035,322 | 591.33M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.93B | 1.78% | 897,681 | 1.01B |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.86B | -0.35% | 628,813 | 7.50M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.81B | -3.65% | 1,534,172 | - |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -2.13% | 157,244 | 290.54M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.52B | -4.08% | 1,117,747 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.11B | 0.51% | 1,489,591 | 1.14B |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.86B | 1.22% | 1,013,091 | - |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.85B | -0.42% | 1,370,091 | - |
| 59 | PBLS | Parabilis Medicines, Inc. | 4.75B | -2.36% | 340,269 | 148.00K |
| 60 | ELVN | Enliven Therapeutics, Inc. | 4.48B | 2.22% | 1,255,203 | - |
| 61 | CELC | Celcuity Inc. | 4.44B | -2.93% | 513,979 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.33B | 1.65% | 2,639,366 | 10.35M |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.13B | 2.64% | 2,088,598 | 53.81M |
| 64 | MANE | Veradermics, Incorporated | 4.11B | -4.24% | 717,276 | - |
| 65 | LEGN | Legend Biotech Corporation | 4.06B | -4.03% | 1,930,131 | 1.27B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.93B | 3.09% | 265,977 | 890.79M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.88B | -1.95% | 1,745,763 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 3.87B | -2.89% | 1,321,109 | 3.60M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 3.86B | 0.93% | 786,604 | 234.13M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.84B | -0.73% | 1,251,622 | 117.00M |
| 71 | IOVA | Iovance Biotherapeutics, Inc. | 3.65B | -2.77% | 15,717,213 | 324.97M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.49B | -0.16% | 822,243 | - |
| 73 | ABCL | AbCellera Biologics Inc. | 3.44B | -6.27% | 6,503,522 | 66.17M |
| 74 | QURE | uniQure N.V. | 3.29B | -1.88% | 920,824 | 18.67M |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -3.66% | 1,154,211 | 7.12M |
| 76 | MBX | MBX Biosciences, Inc. | 3.20B | 0.09% | 530,948 | - |
| 77 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20B | 0.15% | 413,947 | 606.33M |
| 78 | CLDX | Celldex Therapeutics, Inc. | 3.19B | 0.47% | 416,812 | 158.00K |
| 79 | IMNM | Immunome, Inc. | 3.18B | -1.79% | 1,817,476 | 4.02M |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | -1.20% | 1,128,430 | 463.98M |
| 81 | IRON | Disc Medicine, Inc. | 3.11B | 1.42% | 277,235 | - |
| 82 | ALMS | Alumis Inc. | 2.98B | -4.72% | 709,168 | 7.40M |
| 83 | SLS | SELLAS Life Sciences Group, Inc. | 2.89B | -7.34% | 8,795,669 | - |
| 84 | ZLAB | Zai Lab Limited | 2.88B | -1.42% | 1,151,324 | 449.61M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.83B | -4.81% | 1,244,097 | 156.04M |
| 86 | ATAI | AtaiBeckley Inc. | 2.74B | - | 12,304,756 | 4.47M |
| 87 | NRIX | Nurix Therapeutics, Inc. | 2.73B | -1.68% | 874,202 | 36.77M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.72B | -1.11% | 1,131,047 | 71.13M |
| 89 | PHVS | Pharvaris N.V. | 2.62B | 2.87% | 691,816 | - |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 0.67% | 1,229,864 | - |
| 91 | PGEN | Precigen, Inc. | 2.57B | -0.42% | 3,349,519 | 85.72M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | -0.43% | 1,532,989 | 717.00M |
| 93 | NKTR | Nektar Therapeutics | 2.52B | -0.45% | 747,929 | 54.59M |
| 94 | VERA | Vera Therapeutics, Inc. | 2.43B | 4.48% | 2,328,411 | - |
| 95 | NUVB | Nuvation Bio Inc. | 2.37B | -2.45% | 3,012,367 | 169.90M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -2.71% | 2,358,142 | 52.06M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.37B | 2.26% | 365,421 | 20.00M |
| 98 | KOD | Kodiak Sciences Inc. | 2.33B | -2.90% | 717,479 | - |
| 99 | GENB | Generate Biomedicines, Inc. | 2.27B | 9.93% | 2,498,686 | 26.48M |
| 100 | URGN | UroGen Pharma Ltd. | 2.26B | -1.49% | 849,674 | 188.73M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 0.92% | 486,051 | 959.90M |
| 102 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | -1.48% | 587,117 | - |
| 103 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -0.48% | 686,257 | 311.51M |
| 104 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.19B | -2.43% | 6,963,852 | 208.78M |
| 105 | MESO | Mesoblast Limited | 2.19B | -2.12% | 177,673 | 65.38M |
| 106 | COAG | Hemab Therapeutics Holdings, Inc. | 2.18B | -5.07% | 336,957 | - |
| 107 | VCEL | Vericel Corporation | 2.17B | -0.89% | 812,268 | 306.30M |
| 108 | XNCR | Xencor, Inc. | 2.16B | 4.30% | 704,131 | 104.97M |
| 109 | KLRA | Kailera Therapeutics, Inc. | 2.14B | -3.67% | 549,359 | - |
| 110 | ADMA | ADMA Biologics, Inc. | 2.14B | -2.95% | 1,962,811 | 512.28M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 2.10B | 2.61% | 315,492 | - |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.09B | 0.09% | 475,820 | 27.59M |
| 113 | BHVN | Biohaven Ltd. | 2.07B | -1.23% | 1,308,721 | - |
| 114 | ZBIO | Zenas BioPharma, Inc. | 2.06B | -1.98% | 480,995 | 1.00M |
| 115 | ZYME | Zymeworks Inc. | 2.04B | 0.35% | 749,854 | 37.13M |
| 116 | NBTX | Nanobiotix S.A. | 2.02B | -8.93% | 223,827 | 38.27M |
| 117 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -1.36% | 635,627 | 98.34M |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -1.97% | 927,833 | 5.49M |
| 119 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.04% | 1,255,422 | - |
| 120 | KARD | Kardigan, Inc. | 1.93B | -1.81% | 279,209 | - |
| 121 | GHRS | GH Research PLC | 1.93B | -0.81% | 162,742 | - |
| 122 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -3.51% | 1,380,832 | 1.97B |
| 123 | SEPN | Septerna, Inc. | 1.89B | 1.30% | 520,417 | 98.88M |
| 124 | IMCR | Immunocore Holdings plc | 1.89B | -0.73% | 371,083 | 430.78M |
| 125 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.83% | 123,407 | 1.13B |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.87B | -1.65% | 319,816 | - |
| 127 | BRVE | Braveheart Bio, Inc. | 1.76B | -0.29% | 101,992 | - |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.76B | -2.18% | 3,110,237 | 59.51M |
| 129 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -0.41% | 1,443,876 | 252.25M |
| 130 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -7.14% | 15,055,899 | 54.86M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.74B | -0.44% | 1,053,468 | 2.68B |
| 132 | ANAB | AnaptysBio, Inc. | 1.73B | 1.21% | 627,029 | 232.39M |
| 133 | VIR | Vir Biotechnology, Inc. | 1.68B | 1.33% | 1,739,623 | 303.23M |
| 134 | AVLN | Avalyn Pharma Inc. | 1.67B | -1.77% | 158,376 | - |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.64B | 0.58% | 282,274 | 20.00M |
| 136 | AAPG | Ascentage Pharma Group International | 1.56B | -1.71% | 6,533 | 94.61M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.56B | -1.34% | 669,729 | - |
| 138 | TYRA | Tyra Biosciences, Inc. | 1.56B | 0.15% | 321,120 | - |
| 139 | LBRX | LB Pharmaceuticals Inc | 1.56B | 1.24% | 252,629 | - |
| 140 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | 0.39% | 675,209 | - |
| 141 | SLBT | SL Science Holding Limited | 1.55B | 2.26% | 41,833 | 3.27M |
| 142 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 1.26% | 373,388 | 1.30M |
| 143 | INVA | Innoviva, Inc. | 1.52B | -0.19% | 510,221 | 440.00M |
| 144 | ABSI | Absci Corporation | 1.52B | -7.43% | 2,202,289 | 1.56M |
| 145 | NVAX | Novavax, Inc. | 1.46B | -0.89% | 5,559,513 | 413.80M |
| 146 | AKTS | Aktis Oncology, Inc. | 1.44B | 7.94% | 774,236 | 10.06M |
| 147 | MGTX | MeiraGTx Holdings plc | 1.42B | 3.42% | 821,211 | 397.50M |
| 148 | ANRO | Alto Neuroscience, Inc. | 1.42B | 5.75% | 867,824 | - |
| 149 | APMD | Apnimed, Inc. | 1.42B | -8.56% | 244,276 | 120.15M |
| 150 | SVRA | Savara Inc. | 1.41B | -0.54% | 1,322,538 | - |
| 151 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | 0.65% | 617,258 | - |
| 152 | OMER | Omeros Corporation | 1.40B | 0.26% | 1,425,399 | 38.42M |
| 153 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | -5.21% | 1,109,946 | - |
| 154 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.95% | 225,565 | - |
| 155 | LTGO | Latigo Biotherapeutics, Inc. | 1.39B | -1.65% | 234,040 | - |
| 156 | REPL | Replimune Group, Inc. | 1.39B | -0.41% | 2,081,045 | - |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.36B | -1.47% | 483,405 | - |
| 158 | JBIO | Jade Biosciences, Inc. | 1.36B | -0.05% | 595,722 | - |
| 159 | VOR | Vor Biopharma Inc. | 1.34B | -2.78% | 499,951 | - |
| 160 | MNKD | MannKind Corporation | 1.31B | -1.93% | 2,811,849 | 393.63M |
| 161 | MLTX | MoonLake Immunotherapeutics | 1.31B | -2.47% | 1,137,979 | - |
| 162 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -0.95% | 110,486 | - |
| 163 | ODTX | Odyssey Therapeutics, Inc. | 1.21B | -4.70% | 257,412 | 99.00K |
| 164 | IMTX | Immatics N.V. | 1.19B | -2.69% | 294,586 | 47.65M |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -2.56% | 513,455 | - |
| 166 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | -3.67% | 1,998,675 | 28.73M |
| 167 | JANX | Janux Therapeutics, Inc. | 1.14B | 6.96% | 1,451,913 | 24.00M |
| 168 | SANA | Sana Biotechnology, Inc. | 1.13B | -3.32% | 1,924,652 | - |
| 169 | KURA | Kura Oncology, Inc. | 1.10B | 4.29% | 2,673,175 | 77.23M |
| 170 | IVA | Inventiva S.A. | 1.09B | 0.43% | 648,488 | 7.94M |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.03B | -2.82% | 759,038 | 59.00K |
| 172 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.87% | 1,675,365 | 41.47M |
| 173 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.19% | 18,139,879 | 181.72M |
| 174 | WVE | Wave Life Sciences, Inc. | 1.01B | -3.21% | 4,553,294 | 65.37M |
| 175 | CADL | Candel Therapeutics, Inc. | 984.03M | -2.06% | 956,961 | - |
| 176 | SLDB | Solid Biosciences Inc. | 982.18M | -1.51% | 1,114,771 | - |
| 177 | GERN | Geron Corporation | 976.56M | - | 13,099,258 | 204.56M |
| 178 | IMMX | Immix Biopharma, Inc. | 973.65M | -0.37% | 1,419,988 | - |
| 179 | ANNX | Annexon, Inc. | 959.27M | -0.20% | 3,194,931 | - |
| 180 | DSGN | Design Therapeutics, Inc. | 953.12M | 1.60% | 408,409 | - |
| 181 | HELP | Cybin Inc. | 951.24M | 3.42% | 1,862,780 | - |
| 182 | CLYM | Climb Bio, Inc. | 941.95M | -5.09% | 1,177,758 | - |
| 183 | ARDX | Ardelyx, Inc. | 931.96M | -3.86% | 5,210,409 | 450.89M |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 928.83M | -1.56% | 1,272,811 | 8.22M |
| 185 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | -2.43% | 721,985 | - |
| 186 | ANL | Adlai Nortye Ltd. | 911.87M | 3.36% | 185,760 | 18.06M |
| 187 | FTH | Faeth Therapeutics, Inc. | 896.92M | 8.47% | 448,451 | - |
| 188 | ATTO | Attovia Therapeutics, Inc. | 887.26M | -0.87% | 80,991 | 1.35M |
| 189 | TBPH | Theravance Biopharma, Inc. | 883.14M | - | 407,232 | 104.31M |
| 190 | SGP | SpyGlass Pharma, Inc. | 878.34M | -0.94% | 70,133 | - |
| 191 | DBVT | DBV Technologies S.A. | 862.94M | -2.82% | 122,736 | 5.04M |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 850.21M | -2.78% | 1,474,707 | 92.01M |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 842.65M | -1.70% | 201,668 | 276.79M |
| 194 | PHAR | Pharming Group N.V. | 839.49M | -3.29% | 23,168 | 366.48M |
| 195 | AURA | Aura Biosciences, Inc. | 819.27M | 1.28% | 843,809 | - |
| 196 | ACHV | Achieve Life Sciences, Inc. | 817.05M | -0.63% | 920,287 | - |
| 197 | OCS | Oculis Holding AG | 813.63M | 0.73% | 150,346 | 1.45M |
| 198 | OBX | Obsidian Therapeutics, Inc. | 810.20M | -6.03% | 133,093 | - |
| 199 | SLN | Silence Therapeutics plc | 796.57M | -0.30% | 721,979 | 615.00K |
| 200 | NGNE | Neurogene Inc. | 793.25M | 2.61% | 439,094 | 925.00K |
| 201 | STTK | Shattuck Labs, Inc. | 792.87M | 4.91% | 2,054,932 | 1.00M |
| 202 | NVCT | Nuvectis Pharma, Inc. | 777.72M | 1.32% | 231,127 | - |
| 203 | DRUG | Bright Minds Biosciences Inc. | 774.85M | -0.51% | 107,834 | - |
| 204 | MNPR | Monopar Therapeutics Inc. | 747.47M | 3.38% | 239,170 | - |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 732.79M | 0.66% | 338,518 | - |
| 206 | CBIO | Crescent Biopharma, Inc. | 726.33M | -1.05% | 131,534 | 11.88M |
| 207 | ASMB | Assembly Biosciences, Inc. | 718.32M | 2.62% | 383,866 | 74.85M |
| 208 | CTMX | CytomX Therapeutics, Inc. | 716.89M | 0.30% | 3,191,673 | 18.30M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 712.97M | -3.08% | 222,279 | - |
| 210 | SCTX | Scribe Therapeutics Inc. | 702.70M | 9.14% | 526,368 | 36.28M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 701.35M | -2.87% | 4,336,740 | 4.64M |
| 212 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | -1.85% | 784,381 | 136.07M |
| 213 | PHAT | Phathom Pharmaceuticals, Inc. | 687.86M | -2.37% | 992,684 | 239.66M |
| 214 | OABI | OmniAb, Inc. | 684.79M | 8.78% | 1,937,827 | 38.46M |
| 215 | GYRE | Gyre Therapeutics, Inc. | 682.86M | -6.80% | 53,275 | 109.82M |
| 216 | PRLD | Prelude Therapeutics Incorporated | 666.38M | -2.41% | 515,609 | 22.42M |
| 217 | CRMD | CorMedix Inc. | 645.38M | 0.98% | 1,012,097 | 462.25M |
| 218 | VALN | Valneva SE | 635.77M | -3.16% | 21,945 | 163.30M |
| 219 | SGMT | Sagimet Biosciences Inc. | 634.64M | -0.39% | 1,242,172 | - |
| 220 | AGMB | AgomAb Therapeutics NV | 631.36M | -3.25% | 31,651 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 625.64M | -3.26% | 261,078 | - |
| 222 | AUTL | Autolus Therapeutics plc | 622.82M | -2.90% | 1,222,452 | 117.39M |
| 223 | MDXG | MiMedx Group, Inc. | 622.40M | -1.39% | 846,655 | 355.17M |
| 224 | VSTM | Verastem, Inc. | 621.27M | -0.44% | 1,166,440 | 87.53M |
| 225 | ARVN | Arvinas, Inc. | 610.71M | -0.27% | 500,357 | 316.70M |
| 226 | ALT | Altimmune, Inc. | 604.95M | - | 2,715,766 | 31.00K |
| 227 | EIKN | Eikon Therapeutics, Inc. | 604.48M | -2.02% | 398,267 | - |
| 228 | ZURA | Zura Bio Limited | 603.72M | 7.69% | 8,076,615 | - |
| 229 | ENTX | Entera Bio Ltd. | 592.15M | 5.88% | 257,945 | 42.00K |
| 230 | PRME | Prime Medicine, Inc. | 578.19M | -4.13% | 2,266,016 | 4.07M |
| 231 | ARTV | Artiva Biotherapeutics, Inc. | 563.21M | 5.40% | 306,971 | 251.00K |
| 232 | OVID | Ovid Therapeutics Inc. | 550.74M | 0.71% | 1,229,613 | 1.58M |
| 233 | SPRY | ARS Pharmaceuticals, Inc. | 532.04M | -2.82% | 1,935,965 | 116.93M |
| 234 | RGNX | REGENXBIO Inc. | 531.74M | -24.86% | 5,441,073 | 174.48M |
| 235 | MPLT | MapLight Therapeutics, Inc. | 526.85M | 1.34% | 501,062 | - |
| 236 | CABA | Cabaletta Bio, Inc. | 525.59M | -0.96% | 3,107,001 | - |
| 237 | RZLT | Rezolute, Inc. | 523.38M | -1.57% | 1,297,270 | - |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 509.59M | -2.14% | 565,129 | - |
| 239 | CCCC | C4 Therapeutics, Inc. | 504.40M | 2.50% | 1,624,140 | 35.04M |
| 240 | EVMN | Evommune, Inc. | 496.11M | -2.50% | 228,578 | 10.00M |
| 241 | BLSM | BlossomHill Therapeutics, Inc. | 491.22M | -2.14% | 155,960 | - |
| 242 | RLMD | Relmada Therapeutics, Inc. | 488.55M | -1.08% | 935,746 | - |
| 243 | QTTB | Q32 Bio Inc. | 487.03M | 2.44% | 690,838 | 53.74M |
| 244 | PROK | ProKidney Corp. | 486.74M | - | 980,539 | 818.00K |
| 245 | PRTA | Prothena Corporation plc | 482.05M | -0.63% | 248,117 | 54.53M |
| 246 | PBYI | Puma Biotechnology, Inc. | 470.78M | -1.30% | 266,136 | 231.24M |
| 247 | OCGN | Ocugen, Inc. | 461.19M | -2.16% | 2,878,120 | 4.58M |
| 248 | EDIT | Editas Medicine, Inc. | 460.74M | -3.54% | 2,055,433 | 47.01M |
| 249 | DNA | Ginkgo Bioworks Holdings, Inc. | 456.57M | -8.38% | 1,075,545 | 132.42M |
| 250 | IKT | Inhibikase Therapeutics, Inc. | 455.19M | 4.60% | 734,649 | 1.00 |
| 251 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.15M | 8.17% | 1,352,799 | - |
| 252 | AVIR | Atea Pharmaceuticals, Inc. | 441.93M | 1.47% | 99,434 | - |
| 253 | BNTC | Benitec Biopharma Inc. | 436.64M | -5.71% | 122,507 | - |
| 254 | CMPX | Compass Therapeutics, Inc. | 432.21M | - | 974,007 | 850.00K |
| 255 | VOGX | Vogenx, Inc. | 427.69M | 4.10% | 409,980 | - |
| 256 | LRMR | Larimar Therapeutics, Inc. | 422.75M | -3.11% | 944,442 | - |
| 257 | VTVT | vTv Therapeutics Inc. | 421.08M | 1.91% | 17,994 | 36.84M |
| 258 | EYPT | EyePoint, Inc. | 419.85M | -8.46% | 3,486,432 | 2.79M |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 410.67M | 4.68% | 357,435 | 65.26M |
| 260 | FHTX | Foghorn Therapeutics Inc. | 407.98M | -2.83% | 402,911 | 36.74M |
| 261 | ARCT | Arcturus Therapeutics Holdings Inc. | 407.59M | 6.62% | 2,300,919 | 29.37M |
| 262 | LXEO | Lexeo Therapeutics, Inc. | 403.65M | 0.82% | 518,496 | - |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 401.54M | 0.25% | 299,166 | 15.85M |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 399.77M | 0.97% | 218,901 | 59.22M |
| 265 | CAPR | Capricor Therapeutics, Inc. | 395.35M | 8.11% | 20,045,000 | 11.13M |
| 266 | GALT | Galectin Therapeutics Inc. | 391.30M | 5.43% | 227,561 | - |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 387.50M | 0.57% | 913,298 | - |
| 268 | IPSC | Century Therapeutics, Inc. | 383.88M | 2.42% | 360,755 | 109.16M |
| 269 | CUVL | Clinuvel Pharmaceuticals Limited | 372.28M | -4.87% | 26,597 | 64.24M |
| 270 | UPB | Upstream Bio, Inc. | 362.04M | -5.16% | 538,503 | 3.16M |
| 271 | LYEL | Lyell Immunopharma, Inc. | 361.21M | -5.09% | 73,235 | 27.00K |
| 272 | ZNTL | Zentalis Pharmaceuticals, Inc. | 355.97M | -1.70% | 988,288 | 26.87M |
| 273 | DMAC | DiaMedica Therapeutics Inc. | 351.60M | - | 84,616 | - |
| 274 | PALI | Palisade Bio, Inc. | 350.28M | -4.29% | 1,529,431 | 500.00K |
| 275 | ABEO | Abeona Therapeutics Inc. | 346.54M | -0.49% | 848,164 | 25.52M |
| 276 | AGEN | Agenus Inc. | 345.31M | -5.19% | 772,887 | 132.69M |
| 277 | PRQR | ProQR Therapeutics N.V. | 342.93M | 3.85% | 1,041,787 | 21.05M |
| 278 | STRO | Sutro Biopharma, Inc. | 339.75M | -2.61% | 275,914 | 45.70M |
| 279 | IRD | Opus Genetics, Inc. | 335.28M | -0.49% | 812,139 | 9.86M |
| 280 | IMRX | Immuneering Corporation | 335.13M | -2.26% | 400,513 | - |
| 281 | SABS | SAB Biotherapeutics, Inc. | 329.37M | -4.23% | 602,358 | 114.70K |
| 282 | YDES | YD Bio Limited | 327.69M | -0.64% | 18,536 | 510.36K |
| 283 | VCRE | Vicore Pharma Holding AB (publ) | 327.03M | -8.00% | 32,284 | 412.09K |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 326.97M | 1.49% | 249,509 | 31.98M |
| 285 | VNDA | Vanda Pharmaceuticals Inc. | 322.27M | 0.95% | 774,241 | 215.72M |
| 286 | RNAC | Cartesian Therapeutics, Inc. | 304.37M | 0.20% | 104,238 | 1.48M |
| 287 | BCYC | Bicycle Therapeutics plc | 303.07M | -0.92% | 144,013 | 61.21M |
| 288 | IFRX | InflaRx N.V. | 302.10M | -2.38% | 337,005 | -11.54K |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 292.98M | 0.26% | 856,008 | 80.00M |
| 290 | FATE | Fate Therapeutics, Inc. | 292.36M | 4.72% | 1,310,535 | 6.49M |
| 291 | TTRX | Turn Therapeutics Inc. | 288.35M | 2.33% | 70,229 | - |
| 292 | AVXL | Anavex Life Sciences Corp. | 288.21M | -4.01% | 457,117 | - |
| 293 | NMRA | Neumora Therapeutics, Inc. | 286.54M | -6.44% | 1,102,495 | - |
| 294 | ACIU | AC Immune SA | 284.36M | -1.38% | 370,493 | 21.67M |
| 295 | SRZN | Surrozen, Inc. | 281.73M | -0.08% | 163,644 | 11.51M |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 278.20M | 3.17% | 240,084 | 7.15M |
| 297 | IVVD | Invivyd, Inc. | 277.81M | -5.42% | 4,051,800 | 58.37M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 277.37M | -1.16% | 1,142,019 | - |
| 299 | LCTX | Lineage Cell Therapeutics, Inc. | 275.67M | 0.93% | 607,277 | 13.08M |
| 300 | ALXO | ALX Oncology Holdings Inc. | 275.17M | -2.45% | 273,462 | - |
| 301 | CAMP | Camp4 Therapeutics Corporation | 271.09M | -3.57% | 109,475 | 4.22M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 264.30M | -3.17% | 184,247 | 4.69M |
| 303 | ADAG | Adagene Inc. | 261.86M | -2.99% | 159,179 | 9.29M |
| 304 | GLSI | Greenwich LifeSciences, Inc. | 258.04M | 5.46% | 93,206 | - |
| 305 | ALEC | Alector, Inc. | 256.81M | -2.54% | 738,138 | 13.86M |
| 306 | MGNX | MacroGenics, Inc. | 256.07M | -1.95% | 432,773 | 175.14M |
| 307 | NAGE | Niagen Bioscience, Inc. | 254.53M | - | 415,719 | 129.08M |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 253.37M | -0.44% | 59,795 | 1.80M |
| 309 | SION | Sionna Therapeutics, Inc. | 252.74M | 5.67% | 1,590,576 | - |
| 310 | PYXS | Pyxis Oncology, Inc. | 246.89M | -3.90% | 837,396 | 11.04M |
| 311 | CGEN | Compugen Ltd. | 245.34M | -0.96% | 218,356 | 74.00M |
| 312 | CLLS | Cellectis S.A. | 233.79M | -6.31% | 17,199 | 63.82M |
| 313 | DTIL | Precision BioSciences, Inc. | 233.23M | -4.52% | 232,699 | 45.06M |
| 314 | RNA | Atrium Therapeutics, Inc. | 232.98M | 3.18% | 140,452 | 35.84M |
| 315 | NERV | Minerva Neurosciences, Inc. | 229.67M | -0.62% | 111,845 | - |
| 316 | TARA | Protara Therapeutics, Inc. | 228.70M | 0.52% | 229,831 | - |
| 317 | IMUX | Immunic, Inc. | 224.59M | -0.24% | 140,070 | - |
| 318 | ABOS | Acumen Pharmaceuticals, Inc. | 222.38M | -2.69% | 275,962 | - |
| 319 | PEPG | PepGen Inc. | 220.94M | 1.59% | 482,740 | - |
| 320 | NBP | NovaBridge Biosciences | 218.58M | -5.50% | 271,588 | - |
| 321 | NGEN | NervGen Pharma Corp. | 215.05M | 7.53% | 1,092,709 | - |
| 322 | KROS | Keros Therapeutics, Inc. | 213.74M | -2.27% | 217,045 | 15.01M |
| 323 | TNXP | Tonix Pharmaceuticals Holding Corp. | 213.53M | -0.80% | 249,883 | 29.10M |
| 324 | ANTX | AN2 Therapeutics, Inc. | 212.46M | -3.10% | 171,420 | - |
| 325 | ACOG | Alpha Cognition Inc. | 212.33M | - | 168,396 | 15.26M |
| 326 | VYGR | Voyager Therapeutics, Inc. | 211.97M | 1.47% | 405,975 | 34.46M |
| 327 | CHRS | Coherus Oncology, Inc. | 210.12M | -4.23% | 1,044,969 | 50.94M |
| 328 | CNXU | Conexeu Sciences Inc. | 208.98M | -12.15% | 407,325 | - |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 206.76M | 2.99% | 1,311,671 | - |
| 330 | IPHA | Innate Pharma S.A. | 205.82M | -2.43% | 58,901 | 10.57M |
| 331 | MSLE | Satellos Bioscience Inc. | 203.85M | -5.39% | 16,313 | - |
| 332 | ORMP | Oramed Pharmaceuticals Inc. | 200.50M | 0.21% | 90,738 | 2.00M |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 194.18M | 1.26% | 409,879 | 80.62M |
| 334 | KRRO | Korro Bio, Inc. | 192.46M | -0.83% | 70,310 | 2.38M |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 192.23M | 1.37% | 67,744 | 5.54M |
| 336 | NKTX | Nkarta, Inc. | 185.51M | -2.63% | 449,566 | - |
| 337 | HUMA | Humacyte, Inc. | 183.96M | 3.11% | 3,757,405 | 2.12M |
| 338 | CDXS | Codexis, Inc. | 181.78M | -0.60% | 1,359,729 | 77.68M |
| 339 | CRBU | Caribou Biosciences, Inc. | 175.82M | -1.20% | 761,404 | 10.04M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 170.52M | -2.28% | 1,090,998 | 1.50M |
| 341 | SPRB | Spruce Biosciences, Inc. | 168.56M | 13.71% | 138,303 | 697.00K |
| 342 | CUE | Cue Biopharma, Inc. | 168.39M | -3.34% | 135,946 | 37.66M |
| 343 | MDWD | MediWound Ltd. | 167.83M | -1.59% | 101,560 | 11.86M |
| 344 | MOLN | Molecular Partners AG | 165.16M | - | 1,910 | 856.30K |
| 345 | MENS | Jyong Biotech Ltd. | 164.80M | 1.83% | 18,951 | - |
| 346 | OKUR | OnKure Therapeutics, Inc. | 157.53M | -1.27% | 421,073 | - |
| 347 | INDP | Indaptus Therapeutics, Inc. | 154.56M | -10.08% | 292,694 | - |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 151.29M | -3.24% | 3,965,674 | 1.34M |
| 349 | KZIA | Kazia Therapeutics Limited | 150.84M | -1.53% | 61,792 | 1.27M |
| 350 | AARD | Aardvark Therapeutics, Inc. | 150.57M | 0.88% | 83,295 | - |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 149.26M | -3.09% | 897,453 | 3.39M |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 148.75M | -5.15% | 702,130 | - |
| 353 | TLSA | Tiziana Life Sciences Ltd | 148.70M | 0.88% | 958,916 | - |
| 354 | OTLK | Outlook Therapeutics, Inc. | 148.26M | -5.90% | 14,399,617 | -1.16M |
| 355 | MIST | Milestone Pharmaceuticals Inc. | 146.55M | -1.42% | 1,561,865 | 2.34M |
| 356 | CNTB | Connect Biopharma Holdings Limited | 144.84M | -2.54% | 427,623 | 2.95M |
| 357 | LENZ | LENZ Therapeutics, Inc. | 144.22M | -1.92% | 497,905 | 21.48M |
| 358 | EQ | Equillium, Inc. | 139.50M | -4.76% | 326,551 | 4.39M |
| 359 | HURA | TuHURA Biosciences, Inc. | 137.01M | 7.50% | 143,221 | - |
| 360 | PMN | ProMIS Neurosciences, Inc. | 132.72M | 2.00% | 38,557 | - |
| 361 | CBUS | Cibus, Inc. | 132.22M | 1.76% | 116,150 | 4.35M |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 129.25M | 5.93% | 4,590,967 | 65.34K |
| 363 | VANI | Vivani Medical, Inc. | 124.48M | - | 174,290 | - |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 123.81M | -2.49% | 345,016 | 70.00M |
| 365 | ANIX | Anixa Biosciences, Inc. | 123.16M | -2.43% | 138,754 | - |
| 366 | RANI | Rani Therapeutics Holdings, Inc. | 122.53M | -0.11% | 469,446 | 4.88M |
| 367 | GNLX | Genelux Corporation | 121.89M | - | 341,178 | 8.00K |
| 368 | ENGN | enGene Therapeutics Inc. | 121.25M | 1.69% | 641,898 | - |
| 369 | GUTS | Fractyl Health, Inc. | 119.38M | -3.85% | 1,182,225 | 3.00K |
| 370 | NTHI | NeOnc Technologies Holdings, Inc. | 116.58M | 0.32% | 204,403 | 39.99K |
| 371 | COYA | Coya Therapeutics, Inc. | 116.35M | 1.85% | 147,053 | 8.02M |
| 372 | BMEA | Biomea Fusion, Inc. | 115.25M | 16.06% | 11,427,461 | - |
| 373 | SEER | Seer, Inc. | 112.96M | 0.49% | 207,099 | 14.22M |
| 374 | NAUT | Nautilus Biotechnology, Inc. | 111.39M | -8.30% | 606,771 | 190.00K |
| 375 | YARW | Yarrow Bioscience, Inc. | 110.60M | 8.44% | 207,321 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 107.63M | 0.12% | 486,234 | - |
| 377 | TENX | Tenax Therapeutics, Inc. | 105.97M | 5.71% | 4,120,525 | - |
| 378 | PTHS | Pelthos Therapeutics Inc. | 101.91M | 4.35% | 151,257 | 43.30M |
| 379 | PYPD | PolyPid Ltd. | 101.25M | -2.25% | 124,412 | - |
| 380 | FBIO | Fortress Biotech, Inc. | 97.72M | 2.09% | 603,345 | 68.47M |
| 381 | KLRS | Kalaris Therapeutics, Inc. | 97.60M | -1.20% | 51,384 | - |
| 382 | ACET | Adicet Bio, Inc. | 95.80M | -3.16% | 64,328 | - |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 94.96M | -2.47% | 23,966 | 6.19M |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 94.28M | -0.45% | 170,472 | - |
| 385 | CGTX | Cognition Therapeutics, Inc. | 93.62M | -1.14% | 210,590 | - |
| 386 | PLYX | Polaryx Therapeutics, Inc. | 93.21M | -9.66% | 282,511 | - |
| 387 | ALDX | Aldeyra Therapeutics, Inc. | 91.70M | - | 531,878 | - |
| 388 | ICCC | ImmuCell Corporation | 89.37M | -2.19% | 54,668 | 30.68M |
| 389 | RLYB | Rallybio Corporation | 89.22M | -0.18% | 6,676 | 646.00K |
| 390 | GANX | Gain Therapeutics, Inc. | 87.29M | -0.25% | 302,346 | - |
| 391 | DWTX | Dogwood Therapeutics, Inc. | 87.02M | 2.81% | 99,578 | - |
| 392 | GOSS | Gossamer Bio, Inc. | 85.55M | 13.12% | 46,063,118 | 53.29M |
| 393 | VRCA | Verrica Pharmaceuticals Inc. | 83.66M | 1.04% | 67,849 | 30.32M |
| 394 | CING | Cingulate Inc. | 82.60M | 2.34% | 279,811 | - |
| 395 | MAIA | MAIA Biotechnology, Inc. | 82.11M | -2.88% | 227,987 | - |
| 396 | ELOX | Eloxx Pharmaceuticals, Inc. | 80.69M | -4.70% | 151,527 | - |
| 397 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | 3.54% | 56,355 | - |
| 398 | ATHE | Alterity Therapeutics Limited | 78.73M | -2.14% | 10,595 | 4.43M |
| 399 | OKYO | OKYO Pharma Limited | 78.72M | -2.60% | 38,452 | - |
| 400 | ELTX | Elicio Therapeutics, Inc. | 78.32M | -1.97% | 308,927 | - |
| 401 | CRDF | Cardiff Oncology, Inc. | 77.64M | 13.40% | 1,657,190 | 508.00K |
| 402 | NRXS | NeurAxis, Inc. | 76.23M | -1.30% | 34,115 | 5.32M |
| 403 | MNOV | MediciNova, Inc. | 75.31M | 10.07% | 118,858 | 920.48K |
| 404 | ANVS | Annovis Bio, Inc. | 74.56M | -3.85% | 670,073 | - |
| 405 | LONA | LeonaBio, Inc. | 72.83M | 0.59% | 8,428 | - |
| 406 | OSTX | OS Therapies Incorporated | 71.50M | -2.52% | 438,512 | - |
| 407 | SPRO | Spero Therapeutics, Inc. | 70.76M | -0.41% | 367,261 | 47.00M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 70.59M | -1.30% | 315,989 | - |
| 409 | IBIO | iBio, Inc. | 70.54M | -0.70% | 513,075 | 300.00K |
| 410 | XBIT | XBiotech Inc. | 70.43M | 1.32% | 27,672 | - |
| 411 | BSEM | BioStem Technologies, Inc. | 69.97M | 10.73% | 112,697 | 34.59M |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 69.76M | -1.88% | 168,326 | - |
| 413 | CSBR | Champions Oncology, Inc. | 69.05M | 0.20% | 9,301 | 59.43M |
| 414 | RNTX | Rein Therapeutics Inc. | 69.01M | -2.20% | 447,984 | - |
| 415 | BOLD | Boundless Bio, Inc. | 67.33M | -1.33% | 118,450 | - |
| 416 | SER | Serina Therapeutics, Inc. | 66.80M | -8.36% | 35,878 | 130.00K |
| 417 | INMB | INmune Bio Inc. | 65.50M | 1.72% | 501,226 | 50.00K |
| 418 | HYFT | MindWalk Holdings Corp. | 64.84M | -2.13% | 79,422 | 11.43M |
| 419 | EXOZ | eXoZymes, Inc. | 64.51M | -2.80% | 1,523 | -700.00 |
| 420 | IMA | ImageneBio, Inc. | 63.80M | 2.00% | 13,572 | 800.00K |
| 421 | NTRB | Nutriband Inc. | 62.12M | 9.51% | 253,333 | 1.80M |
| 422 | HRTX | Heron Therapeutics, Inc. | 61.28M | 1.45% | 2,297,976 | 151.18M |
| 423 | XLO | Xilio Therapeutics, Inc. | 60.47M | -0.43% | 2,289 | 64.09M |
| 424 | INKT | MiNK Therapeutics, Inc. | 58.89M | -3.11% | 8,082 | - |
| 425 | RNXT | RenovoRx, Inc. | 56.41M | -5.30% | 264,045 | 1.98M |
| 426 | IMMP | Immutep Limited | 55.99M | -0.03% | 202,024 | 5.28M |
| 427 | TCRX | TScan Therapeutics, Inc. | 54.18M | 2.54% | 194,411 | 7.11M |
| 428 | TIL | Instil Bio, Inc. | 52.97M | 3.03% | 12,787 | - |
| 429 | ALPS | Alps Group Inc | 52.42M | -1.56% | 99,803 | 3.74M |
| 430 | ATYR | aTyr Pharma, Inc. | 51.99M | 5.68% | 670,798 | 190.00K |
| 431 | APLM | Apollomics, Inc. | 50.74M | -5.02% | 1,133 | 8.84M |
| 432 | HYPD | Hyperion DeFi, Inc. | 50.66M | 2.52% | 528,971 | 1.40M |
| 433 | IBO | Impact BioMedical Inc. | 48.84M | -5.62% | 14,135 | 35.00K |
| 434 | MCRB | Seres Therapeutics, Inc. | 46.33M | 2.19% | 74,726 | 1.88M |
| 435 | MREO | Mereo BioPharma Group plc | 46.23M | -0.31% | 795,160 | 500.00K |
| 436 | GRCE | Grace Therapeutics, Inc. | 45.86M | -0.91% | 86,589 | - |
| 437 | RNAZ | TransCode Therapeutics, Inc. | 45.71M | -5.92% | 76,288 | - |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 45.71M | -1.63% | 211,095 | 13.56M |
| 439 | FLNA | Filana Therapeutics, Inc. | 44.93M | -3.23% | 121,734 | - |
| 440 | VRXA | Veraxa Biotech AG | 44.89M | -8.72% | 301,827 | - |
| 441 | TVGN | Tevogen Inc. | 44.34M | 0.89% | 4,558 | - |
| 442 | VERU | Veru Inc. | 44.16M | -1.89% | 101,302 | 16.89M |
| 443 | ALGS | Aligos Therapeutics, Inc. | 43.27M | 3.90% | 33,197 | 31.52M |
| 444 | HOWL | Werewolf Therapeutics, Inc. | 42.93M | 1.12% | 11,679,138 | 21.00M |
| 445 | CNTX | Context Therapeutics Inc. | 42.76M | -6.94% | 1,801,647 | - |
| 446 | EDSA | Edesa Biotech, Inc. | 42.42M | -0.68% | 101,404 | - |
| 447 | KPTI | Karyopharm Therapeutics Inc. | 42.19M | -5.10% | 862,424 | 146.62M |
| 448 | CRVO | CervoMed Inc. | 39.76M | 0.38% | 280,320 | 331.30K |
| 449 | BCTX | BriaCell Therapeutics Corp. | 35.13M | -14.99% | 8,697,283 | - |
| 450 | LITS | Lite Strategy, Inc. | 35.05M | 4.07% | 332,165 | - |
| 451 | RADX | Radiopharm Theranostics Limited | 34.13M | - | 73,068 | 10.86M |
| 452 | QNCX | Quince Therapeutics, Inc. | 34.05M | -1.33% | 5,703 | - |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 33.01M | -4.55% | 64,353 | 35.09M |
| 454 | KYNB | Kyntra Bio, Inc. | 32.31M | 6.12% | 25,506 | 4.62M |
| 455 | ESLA | Estrella Immunopharma, Inc. | 31.97M | -0.04% | 20,274 | - |
| 456 | IGC | IGC Pharma, Inc. | 31.08M | -2.40% | 913,476 | 1.11M |
| 457 | ACTU | Actuate Therapeutics, Inc. | 29.54M | -3.15% | 179,284 | - |
| 458 | BYSI | BeyondSpring Inc. | 29.16M | -1.51% | 26,876 | 1.88M |
| 459 | NNVC | NanoViricides, Inc. | 28.93M | -4.51% | 248,323 | - |
| 460 | EVAX | Evaxion A/S | 28.36M | 2.72% | 175,024 | 7.49M |
| 461 | QNTM | Quantum BioPharma Ltd. | 27.61M | -5.81% | 205,239 | - |
| 462 | GNTA | Genenta Science S.p.A. | 27.13M | -8.73% | 43,082 | - |
| 463 | LTRN | Lantern Pharma Inc. | 26.97M | -9.83% | 150,822 | - |
| 464 | NXTC | NextCure, Inc. | 26.96M | -6.36% | 121,605 | - |
| 465 | LGVN | Longeveron Inc. | 26.71M | -0.84% | 812,400 | 1.19M |
| 466 | ENLV | Enlivex Ltd. | 26.40M | 2.72% | 143,831 | - |
| 467 | ATOS | Atossa Therapeutics, Inc. | 26.35M | 3.94% | 56,713 | - |
| 468 | GRDX | GridAI Technologies Corp. | 25.85M | 2.27% | 151,950 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 25.01M | 7.91% | 237,970 | 3.55M |
| 470 | DYAI | Dyadic International, Inc. | 24.75M | -1.55% | 67,453 | 3.80M |
| 471 | BRNS | Barinthus Biotherapeutics plc | 24.64M | -2.99% | 9,125 | 14.97M |
| 472 | CVM | CEL-SCI Corporation | 24.27M | -2.82% | 147,259 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 24.04M | 0.89% | 354,120 | - |
| 474 | CLRB | Cellectar Biosciences, Inc. | 23.82M | -2.70% | 23,170 | - |
| 475 | TVRD | Tvardi Therapeutics, Inc. | 23.74M | -4.30% | 63,238 | - |
| 476 | NIKI | Niki BioSolutions, Inc. | 23.54M | -6.64% | 259,335 | - |
| 477 | CNSY | Cerenome, Inc. | 22.47M | -3.58% | 44,324 | 4.20M |
| 478 | CELU | Celularity Inc. | 22.43M | -3.16% | 37,289 | 26.55M |
| 479 | ALLR | Allarity Therapeutics, Inc. | 22.12M | -2.11% | 32,743 | 345.00K |
| 480 | ABVC | ABVC BioPharma, Inc. | 21.78M | -5.61% | 71,259 | 797.92K |
| 481 | COCP | Cocrystal Pharma, Inc. | 21.38M | -3.48% | 46,043 | 330.00K |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 21.35M | 1.02% | 57,931 | -13.27K |
| 483 | PLRZ | Polyrizon Ltd. | 20.03M | 3.88% | 39,199 | - |
| 484 | CALC | CalciMedica, Inc. | 19.00M | -2.86% | 249,111 | - |
| 485 | NCEL | NewcelX Ltd. | 18.63M | 6.05% | 6,101 | - |
| 486 | PTN | Palatin Technologies, Inc. | 18.50M | 4.85% | 1,667 | 12.88M |
| 487 | CYCN | Cyclerion Therapeutics, Inc. | 18.11M | 1.03% | 89,505 | 1.90M |
| 488 | TPST | Tempest Therapeutics, Inc. | 17.58M | 5.77% | 198,784 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 17.42M | -3.44% | 14,940 | 194.00K |
| 490 | LPCN | Lipocine Inc. | 16.98M | -1.44% | 26,722 | 1.57M |
| 491 | KTTA | Pasithea Therapeutics Corp. | 16.87M | -6.38% | 339,046 | - |
| 492 | PLUR | Pluri Inc. | 16.83M | -8.77% | 38,162 | 1.08M |
| 493 | BIVI | BioVie Inc. | 16.14M | 9.74% | 2,156,319 | - |
| 494 | PBM | Psyence Biomedical Ltd. | 16.10M | -2.54% | 36,948 | - |
| 495 | BCDA | BioCardia, Inc. | 16.05M | 4.95% | 269,561 | 3.00K |
| 496 | LSTA | Lisata Therapeutics, Inc. | 15.86M | 13.55% | 1,082,256 | 100.00K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 15.80M | -4.13% | 376,515 | 7.11M |
| 498 | HIND | Vyome Holdings, Inc. | 15.74M | -0.36% | 3,569 | 129.73K |
| 499 | CMMB | Chemomab Therapeutics Ltd. | 15.72M | 0.46% | 79,731 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 15.51M | -2.26% | 26,898 | - |